Provider Research

This Research Center is intended as a tool for licensed veterinarians when considering the addition of Pinnaclife® Animal Health Products to a patient care plan. Pinnaclife® Animal Health Products and this Research Center are not intended to diagnose, treat, cure, or prevent any disease.

Otitis Externa

(Externa, Wright, Dineen, & Edmonton, 1971; Gates, 2001; Guardabassi, Schwarz, & Lloyd, 2004; Hariharan, Coles, Poole, Lund, & Page, 2006; Roland & Stroman, 2002; Weese & van Duijkeren, 2010) [Full Text]
Externa, I. O., Wright, D. N., Dineen, M., & Edmonton, M. S. (1971). A Model for the Study of. [Full Text]
Gates, G. a. (2001). Safety of ofloxacinotic and other ototopical treatments in animal models and in humans.The Pediatric infectious disease journal, 20(1), 104-7; discussion 120-2. Retrieved from [Full Text]
Guardabassi, L., Schwarz, S., & Lloyd, D. H. (2004). Pet animals as reservoirs of antimicrobial-resistant bacteria.The Journal of antimicrobial chemotherapy, 54(2), 321-32. doi:10.1093/jac/dkh332 [Full Text]
Hariharan, H., Coles, M., Poole, D., Lund, L., & Page, R. (2006). Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa. The Canadian veterinary journal. La revue vétérinairecanadienne, 47(3), 253-5. Retrieved from [Full Text]
Roland, P. S., &Stroman, D. W. (2002). Microbiology of acute otitis externa.The Laryngoscope, 112(7 Pt 1), 1166-77.doi:10.1097/00005537-200207000-00005 [Full Text]
Weese, J. S., & van Duijkeren, E. (2010). Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine.Veterinary microbiology, 140(3-4), 418-29. Elsevier B.V. doi:10.1016/j.vetmic.2009.01.039 [Full Text]